Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation

@inproceedings{Lowes2016CirculatingTC,
  title={Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation},
  author={Lori E. Lowes and Scott V. Bratman and Ryan V Dittamore and Susan J Done and Shana O. Kelley and Sabine Mai and Ryan D. Morin and Alexander W Wyatt and Alison L Allan},
  booktitle={International journal of molecular sciences},
  year={2016}
}
Despite the identification of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) as potential blood-based biomarkers capable of providing prognostic and predictive information in cancer, they have not been incorporated into routine clinical practice. This resistance is due in part to technological limitations hampering CTC and cfDNA analysis, as well… CONTINUE READING

4 Figures & Tables

Topics

Statistics

0102020172018
Citations per Year

Citation Velocity: 9

Averaging 9 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.